SCHEMBL31663569

SCHEMBL31663569

N#Cc1cc(-c2cccnc2)cc(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 5/20 0.47
CYP11B1 P15538 4/20 0.46
CYP19A1 P11511 3/20 0.46
KDM4E B2RXH2 1/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
CYP17A1 P05093 2/20 0.44
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2A6 P11509 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
GLO1 Q04760 1/20 0.43
ADORA2A P29274 1/20 0.43
ADORA1 P30542 1/20 0.43
FLT3 P36888 2/20 0.42
XDH P47989 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31663633 0.85 PIK3CA (0.48) KDM4EGLAGAAALDH1A1CYP1A2
SCHEMBL31663544 0.82 XDH (0.55) CYP11B2CYP11B1CYP19A1KDM4EGLA
SCHEMBL31663512 0.79 ADORA1 (0.49) CYP11B2CYP11B1KDM4EALDH1A1CYP1A2
SCHEMBL29914913 0.79 ADORA2A (0.48) CYP11B2KDM4EGLAGAACNR1
SCHEMBL31663548 0.78 ALDH1A1 (0.49) KDM4EGLAGAAALDH1A1CYP1A2
SCHEMBL28020466 0.77 CYP19A1 (0.59) CYP11B2CYP11B1CYP19A1KDM4ECYP17A1
SCHEMBL31663532 0.77 NPSR1 (0.44) KDM4EGLAGAAALDH1A1CYP1A2
SCHEMBL31663508 0.77 GRIA1 (0.51) KDM4EALDH1A1CYP1A2CYP2A6RXFP1
SCHEMBL31663540 0.77 CNR1 (0.50) CYP11B2CYP11B1CYP19A1KDM4EGLA
SCHEMBL16122010 0.76 CYP11B2 (0.54) CYP11B2CYP11B1CYP19A1KDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 CYP11B2 1221/4885CYP11B1 1903/4885CYP19A1 1257/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 CYP11B2 1221/4885CYP11B1 1903/4885CYP19A1 1257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.